REMSleep patent application approved by the U.S. Patent and Trademark Office

CLEARWATER, FL, Sept. 3, 2024 (GLOBE NEWSWIRE) — REMSleep Holdings, Inc. (OTCQB: RMSL) announces that the United States Patent and Trademark Office has approved another utility patent for its Nasal Ventilation System. REMSleep will file the necessary paperwork to pay for the issuance and REMSleep should receive a patent within approximately 8 weeks. REMSleep will maintain a follow-on application to add improvements and/or modifications to the patent line.

REMSleep is now waiting for silicone raw material from the supply chain to produce inventory for market launch. We expect the materials to arrive at the manufacturer around the first week of October. Production should be available a few days later and we will start shipping samples to distributors etc. During this time we are making all necessary preparations to be fully compliant with FDA regulations for the launch of the Deltawave CPAP pillow interface.